H-CYTE, Inc. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was USD 0.45346 million compared to USD 1.61 million a year ago. Net loss was USD 10.3 million compared to USD 4.8 million a year ago.

Basic loss per share from continuing operations was USD 35.06 compared to USD 32.93 a year ago.